These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34560955)

  • 1. Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray.
    Arauzo B; Lobera MP; Monzon A; Santamaria J
    Carbohydr Polym; 2021 Dec; 273():118543. PubMed ID: 34560955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity.
    Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
    Int J Pharm; 2013 Jun; 449(1-2):44-58. PubMed ID: 23587967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.
    Tewes F; Bahamondez-Canas TF; Moraga-Espinoza D; Smyth HDC; Watts AB
    Eur J Pharm Biopharm; 2020 Jul; 152():210-217. PubMed ID: 32442738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
    Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT
    Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.
    Yang Y; Tsifansky MD; Wu CJ; Yang HI; Schmidt G; Yeo Y
    Pharm Res; 2010 Jan; 27(1):151-60. PubMed ID: 19847626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy.
    Topal GR; Devrim B; Eryilmaz M; Bozkir A
    J Microencapsul; 2018 Sep; 35(6):533-547. PubMed ID: 30213209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process.
    Farhangi M; Mahboubi A; Kobarfard F; Vatanara A; Mortazavi SA
    Pharm Dev Technol; 2019 Jun; 24(5):584-592. PubMed ID: 30431373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid-decorated antibiotic microparticles for inhaled anti-infective therapy.
    Lee SH; Teo J; Heng D; Zhao Y; Ng WK; Chan HK; Tan RB
    J Pharm Sci; 2014 Apr; 103(4):1115-25. PubMed ID: 24510431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.
    Akdag Cayli Y; Sahin S; Buttini F; Balducci AG; Montanari S; Vural I; Oner L
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1378-1389. PubMed ID: 28420285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.
    Kucukoglu V; Uzuner H; Kenar H; Karadenizli A
    Int J Pharm; 2019 Oct; 569():118578. PubMed ID: 31362096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-induced Synergy for Extended Antimicrobial Potency and Enhanced In Vitro Drug Release of Free Base Ciprofloxacin Nanoplexes.
    Abioye A; Sanyaolu A; Dudzinska P; Adepoju-Bello AA; Coker HAB
    Pharm Nanotechnol; 2020; 8(1):33-53. PubMed ID: 31642799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of pH-sensitive nanocarrier based chitosan-g-poly(itaconic acid) for ciprofloxacin delivery for anti-bacterial application.
    Kumar B; Kumar P
    Int J Biol Macromol; 2024 May; 268(Pt 2):131604. PubMed ID: 38641270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antibacterial activity of Egyptian local insects' chitosan-based nanoparticles loaded with ciprofloxacin-HCl.
    Marei N; Elwahy AHM; Salah TA; El Sherif Y; El-Samie EA
    Int J Biol Macromol; 2019 Apr; 126():262-272. PubMed ID: 30584935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of an optimized ciprofloxacin-loaded chitosan nanomicelle with enhanced antibacterial activity.
    Farhangi M; Kobarfard F; Mahboubi A; Vatanara A; Mortazavi SA
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1273-1284. PubMed ID: 29452500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis.
    Tran TT; Yu H; Vidaillac C; Lim AYH; Abisheganaden JA; Chotirmall SH; Hadinoto K
    Int J Pharm; 2019 Mar; 559():382-392. PubMed ID: 30731256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cospray dried antibiotics for dry powder lung delivery.
    Adi H; Young PM; Chan HK; Stewart P; Agus H; Traini D
    J Pharm Sci; 2008 Aug; 97(8):3356-66. PubMed ID: 17990305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin-Loaded Inorganic-Organic Composite Microparticles To Treat Bacterial Lung Infection.
    Tewes F; Brillault J; Lamy B; O'Connell P; Olivier JC; Couet W; Healy AM
    Mol Pharm; 2016 Jan; 13(1):100-12. PubMed ID: 26641021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.